Mutational analysis of the transforming growth factor β receptor type II gene in human ovarian carcinoma

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4227-4232

  Lynch, Melanie A ^a   Nakashima, Ryuichi ^c   Song, Huijuan ^a   DeGroff, Valerie L ^a   Wang, Dian ^b   Enomoto, Takayuki ^c   Weghorst, Christopher M ^a,b,d  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d Department of Internal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; BASE SEQUENCE; CARCINOMA; CODON; CONSERVED SEQUENCE; FEMALE; FRAMESHIFT MUTATION; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; OVARIAN NEOPLASMS; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE DELETION; SURVIVAL ANALYSIS;

EID: 0032190222     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Parker, S., Tong, T., Bolden. S., and Wingo, P. Cancer statistics, 1996. CA Cancer J. Clin., 65: 5-27, 1996.
2. Kristensen, G. B., and Trope. C. Epithelial ovarian carcinoma. Lancet, 349: 113-117, 1997.
3. Parazzini, F. The epidemiology of ovarian cancer. Gynecol. Oncol., 43: 9-23, 1991.
4. Gallion, H. H., and Smith, S. A. Hereditary ovarian cancer. Semin. Surg. Oncol., 10: 249-254, 1994.
5. Watson, P., and Lynch, H. T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer (Phila.), 71: 677-685, 1993.
6. Bewtra, C., Watson, P., Conway, T., Read-Hippee, C., and Lynch, H. T. Hereditary ovarian cancer: a clinicopathological study. Int. J. Gynecol. Pathol., 11: 180-187, 1992.
7. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., and Lindblom, A. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (Lond.), 368: 258-261, 1994.
8. Nicolaides, N. C., Papadopoulos, N., Liu, B., Wei. Y. F., Carter, K. C., Kuben, S. M., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., and Fraser, C. M. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (Lond.), 371 : 75-80, 1994.
9. Arzimanoglou, I.I., Lallas, T., Osborne, M., Barber, H., and Gilbert. F. Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis (Lond.), 17: 1799-1804, 1996.
10. King, B. L., Carcangiu, M. L., Carter, D., Kiechlo, M., Pfisterer, J., Pfleiderer, A., and Kacinski, B. M. Microsatellite instability in ovarian neoplasms. Br. J. Cancer, 72: 376-382, 1995.
11. Fujita, M., Enomoto, T., Yoshino, K., Nomura, T., Buzard. G. S., Inoue, M., and Okudaira, Y. Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int. J. Cancer. 64: 361-366, 1995.
12. Sood, A. K., and Buller, R. E. Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. Oncogene, 13: 2499-2504, 1996.
13. Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Microsatellite instability and mutations of the transforming growth factor βtype II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
14. Myeroff, L. L., Parsons. R., Kim, S. J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y. J., Lee, H. Y., Park, J. G., Lynch, H. T., Roberts. A. B., Vogelstein. B., and Markowitz, S. D. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
15. Derynck, R. TGF-β-receptor-mediated signaling. Trends Biochem. Sci., 19: 549-553, 1994.
16. Attisano, L., Wrana, J. L., Lopez-Casillas, F., and Massague, J. TGF-β receptors and actions. Biochim. Biophys. Acta, 1222: 71-80, 1994.
17. Fynan, T. M., and Reiss, M. Resistance to inhibition of cell growth by transforming growth factor β and its role in oncogenesis. Crit. Rev. Oncog., 4: 493-540, 1993.
18. Massague, J., and Weis-Garcia, F. Serine/threonine kinase receptors: mediators of transforming growth factor β family signals. Cancer Surv., 27: 41-63, 1996.
19. Lu, S. L., Zhang, W. C., Akiyama, Y., Nomizu, T., and Yuasa, Y. Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res., 56: 4595-4598, 1996.
20. Wang, D., Song, H., Lang. J. C., Schuller, D. E., and Weghorst. C. M. Mutation and down-regulation of the transforming growth factor β type II receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis (Lond.), 18: 2285-2290, 1998.
21. Hongyo, T., Buzard, G. S., Calvert, R. J., and Weghorst, C. M. Cold SSCP: a simple, rapid and non-radioactive method for optimized single strand conformation polymor-phism analyses. Nucleic Acids Res., 16: 3637-3642, 1993.
22. Muñoz-Antonia, T., Li, X., Reiss, M., Jackson, R., and Antonia, S. A mutation in the transforming growth factor β type II receptor gene promoter associated with loss of expression. Cancer Res., 56: 4831-4835, 1996.
23. Koli, K. M., and Arteaga, C. L. Predominant cytosolic localization of type II transforming growth factor β receptors in human breast carcinoma cells. Cancer Res., 57: 970-977, 1997.
24. Berchuk, A., Rodriguez, G., Olt. G., Whitaker, R., Boente, M. P., Arrick, B. A., Clarke-Pearson, D. L., and Bast. R. C., Jr. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am. J. Obstet. Gynecol., 166: 676-684, 1992.
25. Hurteau, J., Rodriguez. G. C., Whitaker, R. S., Shain, S., Bast, R. C., Jr., and Berchuk, A. Effect of transforming growth factor β on proliferation of human ovarian cancer cells obtained from ascites. Cancer (Phila.), 74: 93-99, 1994.
26. Henriksen, R., Gobl. E., Wilander, K., Oberg, K., Miyazono. K., and Funa, K. Expression and prognostic significance of TGFβ isotypes, latent TGF-β1 binding protein, TGF-β type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab. Investig., 73: 213-220, 1995.
27. Anderson, M., Muro-Cacho, C., Livingston, S., and Muñoz-Antonia, T. Different intracellular location of transforming growth factor β type II receptor in verrucous carcinoma and squamous cell carcinoma. Proc. Am. Assoc. Cancer Res., 39: 485, 1998.
28. Sue, S. R., Chari, R. S., Kong, F. M., Mills, J. J., Fine. R. L., Jirtle, R. L., and Meyers. W. C. Transforming growth factor-β receptors and mannose 6-phosphate/isulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann. Surg., 222: 171-178, 1995.
29. Lazzereschi, D., Ranieri, A., Mincione, G., Taccogna, S., Nardi, F., and Colletta, G. Human malignant thyroid tumors display reduced levels of transforming growth factor β receptor type II messenger RNA and protein. Cancer Res., 57: 2071-2076. 1997.
30. Lagneaux, L., Delforge, A., Bron, D., Massy, M., Bernier, M., and Stryckmans, P. Heterogenous response of B lymphocytes to transforming growth factor-β in B-cell chronic lymphocytic leukaemia: correlation with the expression of TGF-β receptors. Br. J. Haematol., 97: 612-620, 1997.
31. Gerdes, M. J., Larsen, M., McBride, L., Dang, T. D., Lu, B., and Rowley, D. R. Localization of transforming growth factor-β1 and type II receptor in developing normal human prostate and carcinoma tissues. J. Histochem. Cytochem., 46: 379-388, 1998.
32. Roy, S. K., and Kole, A. R. Ovarian transforming growth factor-β (TGF-β) receptors: in vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-β on receptor expression in human preantral follicles. Mol. Hum. Reprod., 4: 207-214. 1998.
33. Chen, T., DeVries, E. G. E., Hollema, H., and Reiss, M. Frequent mutations in transforming growth factor-β (TGFβ) receptor I (TβR-I) and II (TβR-II) genes in cervical carcinoma. Proc. Am. Assoc. Cancer Res., 39: 282, 3998.
34. Eppert, K., Scherer, S. W., Ozcerlik, H., Pirone, R., Hoodless, P., Kim. H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis. I., Thomsen, G. H., Wrana. J. L., and Attisano, L. MADR2 maps to 18q21-and encodes a TGF-β MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
35. Aral, T., Akiyama, Y., Okabe, S., Ando, M., Endo, M., and Yuasa, Y. Genomic structure of the human Smad 3 gene and its infrequent alterations in colorectal cancers. Cancer Lett., 122: 157-163, 1998.